Advertisements


Acer Therapeutics: Multiple Aces Up Its Sleeve

Acer Therapeutics: Multiple Aces Up Its Sleeve.....»»

Category: topSource: seekingalphaFeb 11th, 2019

Hedge Fund and Insider Trading News: Jeffrey Epstein, Tom Steyer, MSD Capital, Acer Therapeutics Inc (ACER), Greif Inc (GEF), and More

Billionaire Grudge Match Nears As Tom Steyer Talks Up Taking On Trump For The White House (Forbes) Billionaire investor Tom Steyer looks set.....»»

Category: topSource: insidermonkeyJul 13th, 2019

Acer Therapeutics expects restructuring to extend cash runway through 2020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 5th, 2019

Acer Therapeutics reduces headcount to 19 from 48 employees

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 5th, 2019

Acer Therapeutics says pre-commercial activities of EDSIVO have been halted

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 5th, 2019

Good Timing For This Alternative Energy ETF

The ALPS Clean Energy ETF (CBOE: ACES), an exchange traded fund with exposure to multiple clean energy themes, debuted about a year ago and it appears its timing was excellent and not just because the fund is up 30.51% this year. read more.....»»

Category: blogSource: benzingaJul 1st, 2019

Acer Therapeutics: Despite Receiving A Devastating CRL, The Story Isn"t Over

Acer Therapeutics: Despite Receiving A Devastating CRL, The Story Isn"t Over.....»»

Category: topSource: seekingalphaJun 27th, 2019

Acer Therapeutics price target lowered to $10 from $55 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 26th, 2019

Acer Therapeutics price target lowered to $9 from $66 at Roth Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

Mid-Afternoon Market Update: NASDAQ Down 1.5%; Acer Therapeutics Shares Slide

Toward the end of trading Tuesday, the Dow traded down 0.71% to 26,536.70 while the NASDAQ fell 1.5% to 7,884.88. The S&P also fell, dropping 0.87% to 2,919.76. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaJun 25th, 2019

Acer Therapeutics downgraded to Market Perform from Outperform at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

Acer Therapeutics downgraded to Hold from Buy at Needham

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

Acer Therapeutics downgraded to Hold from Buy at Needham

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

Acer Therapeutics downgraded to Market Perform from Outperform at William Blair

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

Acer Therapeutics Shares Plunge On FDA Complete Response Letter

Acer Therapeutics Inc (NASDAQ: ACER) shares were trading down more than 75% Tuesday after it received a letter from the Food and Drug Administration regarding its drug application for Edsivo in┬áthe treatment of vascular Ehlers-Danlos syndrome. read more.....»»

Category: blogSource: benzingaJun 25th, 2019

Acer Therapeutics receives "complete response letter" from FDA regarding NDA for Edsivo

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 25th, 2019

Acer Therapeutics stock resumes trading, plunges 79% premarket after receiving CRL from FDA

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 25th, 2019

Acer Therapeutics Inc trading resumes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

Acer Therapeutics receives complete response letter from FDA for Edsivo NDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

Acer Therapeutics Inc trading halted, news pending

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019

FDA PDUFA Date for Acer Therapeutics for Edviso is June 25, 2019

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2019